- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05017506
The Coronavirus Impact Scale Validity and Reliability Study
Turkish Validity and Reliability Study of The Coronavirus Impact Scale
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
This research; The Turkish validity and reliability study of the "Coronavirus Impact Scale" developed by Stoddard and Kaufman (2020) will be conducted in order to bring a new measurement tool to our country.
Method: This research was planned as a methodological study. Research Question: Is the "Coronavirus Impact Scale" a valid and reliable measurement tool for Turkish society?
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Cumhurıyet Campus
-
Ordu, Cumhurıyet Campus, Kalkun, 52000
- Ordu Univercity
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- At least 18 years old,
- At least primary school graduate,
- Able to communicate verbally and
- Persons who agree to participate in the research will be included in the research.
Exclusion Criteria:
- Psychiatric illness and unable to communicate,
- Having a language problem
- Persons who do not have the skills to read and understand the questionnaire will be excluded from the research.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Andet
- Tidsperspektiver: Fremadrettet
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Coronavirus Impact Scale
Tidsramme: 8 months
|
The Coronovirus Impact Scale was developed by Stoddard and Kaufman (2020) to assess the impact of Covid-19 on people.
The scale consists of 12 questions.
Questions 1-9 in the scale are in 4-point Likert type, 0. There is no change, 1. Mild, 2. Moderate and 3. Severe, and points are taken between 0-3 from these questions.
The questions between 10 and 11 on the scale are in a 5-point Likert type and are scored between 0-4 (indicating that from mild symptoms to death).
However, the number of first degree family members diagnosed with coronavirus in question 10 and the number of relatives or close friends diagnosed with coronavirus in question 11 are not taken into account in the scale.
The 12th question of the scale is open-ended and determines the other aspects that the coronavirus epidemic affects life.
A minimum score of 0 and a maximum score of 35 are obtained from the scale, and as the score increases, the degree of exposure of people to the Corona virus increases.
|
8 months
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ayyuzlum3207*
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .